(56 days)
The Remington Medical Disposable Surgical Extension Cable is an electrical excesson cable. used to transmit signal from, or power or excitation signal to patient-connected electrodes. The cable is bipolar, providing alligator clips at the end of the cable that will be attached to the patient's lead, and a safety plug at the other end that allows electrical connection to the external pacemaker or testing device (i.e. analyzer). The alligator clips are color coded and imprinted with the polarity: The red clips are positive (+) and the black clips are negative (-).
The cable is designed to carry a maximum electrical load of 300 volts, and will be compatible with most external pace makers, pace analyzers, and patient pacing leads currently on the market.
The cable is a sterile, disposable device.
The Remington Medical Disposable Surgical Extension Cable is an electrical excesson cable. used to transmit signal from, or power or excitation signal to patient-connected electrodes. The cable is bipolar, providing alligator clips at the end of the cable that will be attached to the patient's lead, and a safety plug at the other end that allows electrical connection to the external pacemaker or testing device (i.e. analyzer). The alligator clips are color coded and imprinted with the polarity: The red clips are positive (+) and the black clips are negative (-).
The cable is designed to carry a maximum electrical load of 300 volts, and will be compatible with most external pace makers, pace analyzers, and patient pacing leads currently on the market.
The cable is a sterile, disposable device.
Here's the analysis of the provided text regarding acceptance criteria and a study.
Unfortunately, the provided text does not contain any information about acceptance criteria or a study proving device performance. The document is a 510(k) clearance letter from the FDA for a device called "Safe Connect Surgical Cable." This letter confirms that the device is substantially equivalent to legally marketed predicate devices and can therefore be marketed.
While the letter mentions the device's intended use and some specifications (like carrying a maximum electrical load of 300 volts), it does not detail any specific performance metrics, clinical studies, or acceptance criteria that were used to demonstrate its safety or effectiveness beyond substantial equivalence to a predicate device.
Therefore, I cannot populate the table or answer the specific questions you've asked based on this input. The information necessary to describe acceptance criteria and a study (including sample sizes, ground truth establishment, expert qualifications, etc.) is simply not present in this document.
To answer your request, I would need a document that describes the results of a study (clinical or pre-clinical) that was performed to evaluate the performance of the device against predefined criteria.
{0}------------------------------------------------
Public Health Service
Image /page/0/Picture/2 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.
OCT 16 2008
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Remington Medical, Inc. c/o Mr. Don Rosvold 6830 Meadowridge Court Alpharetta, GA 30005
Re: K971968
Trade/Device Name: Safe Connect Surgical Cable Regulation Number: 21 CFR 870.5550 Regulation Name: Patient transducer and electrode cable (including connector) Regulatory Class: II Product Code: DSA Dated (Date on orig SE ltr): July 23, 1997 Received (Date on orig SE 1tr): May 28, 1997
Dear Mr. Rosvold:
This letter corrects our substantially equivalent letter of July 23, 1997.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 - Mr. Don Rosvold
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/dsma/dsmamain.html
Sincerely vours.
eQ.mde
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Page i of 1
510(k) Number (if known): K971968
Safe Connect Surgical Cable Device Name:
Indications For Use:
The Remington Medical Disposable Surgical Extension Cable is an electrical excesson cable. used to transmit signal from, or power or excitation signal to patient-connected electrodes. The cable is bipolar, providing alligator clips at the end of the cable that will be attached to the patient's lead, and a safety plug at the other end that allows electrical connection to the external pacemaker or testing device (i.e. analyzer). The alligator clips are color coded and imprinted with the polarity: The red clips are positive (+) and the black clips are negative (-).
The cable is designed to carry a maximum electrical load of 300 volts, and will be compatible with most external pace makers, pace analyzers, and patient pacing leads currently on the market.
The cable is a sterile, disposable device.
(PLEASE DO WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Christa foremon
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number K971968
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
§ 870.2900 Patient transducer and electrode cable (including connector).
(a)
Identification. A patient transducer and electrode cable (including connector) is an electrical conductor used to transmit signals from, or power or excitation signals to, patient-connected electrodes or transducers.(b)
Classification. Class II (performance standards).